Cytogenetic biomonitoring in buccal mucosa cells of COVID-19 patients: Preliminary findings

10Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: COVID-19 may lead to progressive respiratory failure as a consequence of alveolar damage, resulting in death. The aim of this study was to evaluate cytogenetic damage in oral cells of COVID-19 patients by micronucleus assay. Patients and Methods: A total of 11 COVID-19 patients aged 40.7±9.3 years (5 men and 6 women) were included in this study. For the control group, a total of 15 participants not infected with SARS-CoV- 2 virus were included. The mean age was 41.6±6.2 years (5 men and 10 women). Results: The results showed statistically significant differences (p<0.05) in micronucleated buccal mucosa cells of COVID-19 patients. In addittion, a statistically significant increase in karyolysis and karrhyorexis (p<0.05) was observed in COVID-19 patients compared to control. Conclusion: SARS-CoV-2 virus can induce mutagenesis and cytotoxicity in oral cells.

Cite

CITATION STYLE

APA

Pinto, T. G., Alpire, M. E. S., & Ribeiro, D. A. (2021). Cytogenetic biomonitoring in buccal mucosa cells of COVID-19 patients: Preliminary findings. In Vivo, 35(6), 3495–3499. https://doi.org/10.21873/invivo.12651

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free